SOUTH SAN FRANCISCO, USA and VANCOUVER, BC – ESSA Pharma Inc is pleased to announce that its Securityholders (as defined below) have approved the acquisition of all of the issued and outstanding common… Read More
Anticipated collaboration with leading academic institutions aims to overcome key barriers in cell and gene therapy by targeting solid tumors, enabling in vivo treatment, and radically reducing manufacturing costs Cytiva… Read More
Canada, TO – Innovative Medicines Canada (IMC) applauds the Government of Ontario for its pioneering announcement of the Funding Accelerated for Specific Treatments (FAST) Program, a new initiative designed to significantly… Read More
Approval expands SIMPONI® indication to treat children weighing at least 15 kg with moderately to severely active ulcerative colitis SIMPONI® is the only approved treatment to offer a monthly maintenance dose for… Read More
DUBLIN – Aon plc, a leading global professional services firm, forecasts that medical plan costs worldwide will rise by an average of 9.8 percent in 2026, according to its 2026… Read More
